NISTRI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 1.476
NA - Nord America 1.470
AS - Asia 268
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.217
Nazione #
US - Stati Uniti d'America 1.462
PL - Polonia 864
RU - Federazione Russa 166
IE - Irlanda 131
SE - Svezia 121
IT - Italia 112
CN - Cina 75
HK - Hong Kong 57
SG - Singapore 49
JO - Giordania 33
VN - Vietnam 30
DE - Germania 21
IN - India 16
ES - Italia 12
FI - Finlandia 12
GB - Regno Unito 12
UA - Ucraina 9
CA - Canada 8
CH - Svizzera 5
RO - Romania 5
CZ - Repubblica Ceca 3
IR - Iran 3
TR - Turchia 3
BR - Brasile 2
JP - Giappone 2
EU - Europa 1
FR - Francia 1
NL - Olanda 1
PT - Portogallo 1
Totale 3.217
Città #
Warsaw 864
Fairfield 275
Woodbridge 134
Dublin 131
Ashburn 126
Chandler 115
Seattle 115
Cambridge 109
Houston 96
Wilmington 86
Altamura 45
Lawrence 43
Singapore 38
Hong Kong 36
Princeton 34
Florence 29
Dong Ket 26
Beijing 24
Ann Arbor 23
Medford 17
San Diego 16
Boston 15
Buffalo 15
Shanghai 12
Mumbai 11
Dearborn 10
Falls Church 10
Barcelona 9
Santa Clara 9
Jacksonville 8
Boardman 7
Phoenix 7
New York 6
Norwalk 6
Toronto 6
Chennai 5
Kent 5
Rome 5
Bern 4
Guangzhou 4
Hillsboro 4
Milan 4
Timisoara 4
Brno 3
Fuzhou 3
Madrid 3
Moscow 3
Padova 3
Redwood City 3
Tehran 3
Antakya 2
Bonito 2
Drena 2
Hebei 2
Helsinki 2
Kowloon 2
London 2
Los Angeles 2
Malmo 2
Montecchio Maggiore 2
Naples 2
Siena 2
West Jordan 2
Wuhan 2
Amsterdam 1
Andover 1
Bremen 1
Cavriglia 1
Chicago 1
Chiswick 1
Council Bluffs 1
Evanston 1
Fiesole 1
Gatchina 1
Gloucester 1
Hangzhou 1
Hefei 1
Izmir 1
Kagoya 1
Kilburn 1
Laurel 1
Livorno 1
Montagny 1
Munich 1
Nanjing 1
Nantong 1
Ningbo 1
Olgiate Olona 1
Ottawa 1
Québec 1
Salerno 1
Scandicci 1
Selvazzano Dentro 1
St Petersburg 1
Suzhou 1
Tappahannock 1
Tyumen 1
Vila Nova de Gaia 1
Weitang 1
Zhengzhou 1
Totale 2.633
Nome #
Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. 232
Identification of fibrillin 1 gene mutations in patients with bicuspid aortic valve (BAV) without Marfan syndrome. 225
Feasibility and relevance of right parasternal view for assessing severity and rate of progression of aortic valve stenosis in primary care 205
β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy 165
Genetic bases of bicuspid aortic valve: The contribution of traditional and high-throughput sequencing approaches on research and diagnosis 147
Hemodynamic progression and outcome of asymptomatic aortic stenosis in primary care 146
Role of TGFBR1 and TGFBR2 genetic variants in Marfan syndrome 140
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy 132
A Case Based Approach to Clinical Genetics of Thoracic Aortic Aneurysm/Dissection 129
Bicuspid Aortic Valve: Role of Multiple Gene Variants in Influencing the Clinical Phenotype 128
Echocardiography in patients with hypertrophic cardiomyopathy: Usefulness of old and new techniques in the diagnosis and pathophysiological assessment 126
Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy 126
Bicuspid aortic valve syndrome and fibrillinopathies: potential impact on clinical approach 125
Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study 119
Prevalence and clinical significance of acquired left coronary artery fistulas after surgical myectomy in patients with hypertrophic cardiomyopathy 113
Beta-Blockers for Prevention of Exercise-induced Left Ventricular Outflow Obstruction in Patients with Hypertrophic Cardiomyopathy 105
Another piece in the puzzle of bicuspid aortic valve syndrome 104
Incremental prognostic value of multiparametric echocardiographic assessment for severe aortic stenosis 104
Marfan syndrome: Current perspectives 95
[Paradigm shifts in aortic pathology: clinical and therapeutic implications. Clinical imaging in chronic and acute aortic syndromes. The aorta as a cause of cardiac disease] 88
Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy 84
Evaluation of the appropriateness of the preclinical phase (stage A and stage B) of heart failure Management in Outpatient clinics in Italy rationale and design of the 'VASTISSIMO' study. 77
Awareness and appropriateness of the management of preclinical heart failure in outpatient clinics in Italy: Insights from the VASTISSIMO study: EValuation of the AppropriateneSs of the preclInical phase (Stage A and Stage B) of Heart FaIlure Management in Outpatient Clinics in Italy 68
Stress Echocardiography in Hypertrophic Cardiomyopathy 66
Special subsets of electrocardiographically defined patients: Left bundle branch block, right bundle branch block, and atrial fibrillation 62
Two-Dimensional Aortic Size Normalcy: A Novelty Detection Approach 55
Differential diagnosis between marfan syndrome and loeys–dietz syndrome type 4: A novel chromosomal deletion covering tgfb2 55
[Paradigm shifts in aortic pathology: clinical and therapeutic implications. Biology and pathology of the aortic wall]. 42
Tracking an Elusive Killer: State of the Art of Molecular-Genetic Knowledge and Laboratory Role in Diagnosis and Risk Stratification of Thoracic Aortic Aneurysm and Dissection 16
Totale 3.279
Categoria #
all - tutte 8.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020736 0 0 10 39 113 108 97 118 99 59 77 16
2020/2021668 46 78 14 97 37 67 37 50 63 111 29 39
2021/2022227 4 14 33 4 8 18 11 14 17 16 29 59
2022/2023583 51 125 37 22 31 97 75 27 83 1 24 10
2023/2024212 13 23 26 14 8 35 11 46 5 10 6 15
2024/2025283 68 147 68 0 0 0 0 0 0 0 0 0
Totale 3.279